Results 71 to 80 of about 11,585 (220)
Torsade de Pointes and Persistent QTc Prolongation after Intravenous Amiodarone
We report a case of torsade de pointes after intravenous amiodarone and concurrent hypokalemia. Despite treatment cessation and correction of electrolyte abnormalities, excessive QTc prolongation was noted, which persisted for 14 days.
Anna P. Kotsia +3 more
doaj +1 more source
Pärilik pika QT sündroom [PDF]
Pärilik pika QT sündroom on geneetilise etioloogiaga südame elektrofüsioloogiline häire, mida iseloomustab EKGs QT-aja pikenemine, T-saki anomaaliad ning ventrikulaarse tahhükardia torsade de pointes’i tüüpi paroksüsmid koos sünkoobiga.
Jalas, Tiiu +5 more
core +2 more sources
Machine Learning‐Based Prediction of Drug‐Induced QTc Changes in a Large Finnish Biobank Cohort
ABSTRACT Prolongation of the QT interval is a known precursor to serious arrhythmias and sudden cardiac death, often triggered by medication use. Current medication risk evaluation platforms rely on literature‐based synthesis and may lag behind real‐world developments.
Ville Langén +7 more
wiley +1 more source
Clarithromycin-Induced Long QT Syndrome: A Case Report
Long QT syndrome develops for a number of reasons. The number of non-antiarrhythmic drugs reported to induce QT interval prolongation with or without torsade de pointes continues to increase.
Mecnun Cetin +4 more
doaj +1 more source
The QT interval in lightning injury with implications for the cessation of metabolism hypothesis [PDF]
An hypothesis is presented to provide an alternative to the Cessation of Metabolism hypothesis often invoked in lightning injury. Cessation of Metabolism has been proposed to explain the observation of good recovery after a prolonged period in cardiac ...
Andrews, Christopher J. +2 more
core +1 more source
Pharmacogenetics of Drug-Induced QT Interval Prolongation: An Update [PDF]
A prolonged QT interval is an important risk factor for ventricular arrhythmias and sudden cardiac death. QT prolongation can be caused by drugs. There are multiple risk factors for drug-induced QT prolongation, including genetic variation.
Berg, M.E. (Marten) van den +4 more
core +1 more source
This review presents a process‐oriented framework for vascularized cardiac tissue engineering, highlighting how the coordinated design of cells, biomaterials, and biofabrication strategies enables the functional development or vascularized myocardium for disease modelling and drug discovery.
Yang Liu +9 more
wiley +1 more source
QT prolongation, a risk factor for arrhythmias, can result from genetic variants in one (or more) of the genes governing cardiac repolarization as well as intake of drugs known to affect a cardiac K+ channel encoded by human ether-a-go-go–related gene ...
Tomoko Sakaguchi +13 more
doaj +1 more source
Causal AI in Cardiac Arrhythmia: From Pattern Recognition to Mechanistic Insight
Causal artificial intelligence (AI) in Cardiac Arrhythmia: From Pattern Recognition to Mechanistic Insight. Multimodal cardiac data, including electrocardiograms (ECG), wearable device recordings, cardiac imaging, genetic information, and electronic health records, are integrated to support AI‐based analysis. Traditional AI approaches primarily rely on
Bara AbuBaha +11 more
wiley +1 more source
Sacubitril Does Not Exert Proarrhythmic Effects in Combination with Different Antiarrhythmic Drugs
Background: Previous studies suggest a direct effect of sacubitril on cardiac electrophysiology and indicate potential arrhythmic interactions between sacubitril and antiarrhythmic drugs.
Christian Ellermann +7 more
doaj +1 more source

